[go: up one dir, main page]

FR2716200B1 - Process for the preparation of branched cyclomaltooligosaccharides, in particular branched cyclodextrins. - Google Patents

Process for the preparation of branched cyclomaltooligosaccharides, in particular branched cyclodextrins.

Info

Publication number
FR2716200B1
FR2716200B1 FR9401576A FR9401576A FR2716200B1 FR 2716200 B1 FR2716200 B1 FR 2716200B1 FR 9401576 A FR9401576 A FR 9401576A FR 9401576 A FR9401576 A FR 9401576A FR 2716200 B1 FR2716200 B1 FR 2716200B1
Authority
FR
France
Prior art keywords
branched
cyclomaltooligosaccharides
preparation
cyclodextrins
particular branched
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9401576A
Other languages
French (fr)
Other versions
FR2716200A1 (en
Inventor
Jacques Defaye
Fernandez Jose Manuel Garcia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Commissariat a lEnergie Atomique CEA filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR9401576A priority Critical patent/FR2716200B1/en
Priority to PCT/FR1995/000162 priority patent/WO1995021870A1/en
Publication of FR2716200A1 publication Critical patent/FR2716200A1/en
Application granted granted Critical
Publication of FR2716200B1 publication Critical patent/FR2716200B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR9401576A 1994-02-11 1994-02-11 Process for the preparation of branched cyclomaltooligosaccharides, in particular branched cyclodextrins. Expired - Fee Related FR2716200B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9401576A FR2716200B1 (en) 1994-02-11 1994-02-11 Process for the preparation of branched cyclomaltooligosaccharides, in particular branched cyclodextrins.
PCT/FR1995/000162 WO1995021870A1 (en) 1994-02-11 1995-02-10 Method for the preparation of branched cyclomaltooligosaccharides, in particular, branched cyclodextrines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401576A FR2716200B1 (en) 1994-02-11 1994-02-11 Process for the preparation of branched cyclomaltooligosaccharides, in particular branched cyclodextrins.

Publications (2)

Publication Number Publication Date
FR2716200A1 FR2716200A1 (en) 1995-08-18
FR2716200B1 true FR2716200B1 (en) 1996-04-26

Family

ID=9460005

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9401576A Expired - Fee Related FR2716200B1 (en) 1994-02-11 1994-02-11 Process for the preparation of branched cyclomaltooligosaccharides, in particular branched cyclodextrins.

Country Status (2)

Country Link
FR (1) FR2716200B1 (en)
WO (1) WO1995021870A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746103B1 (en) * 1996-03-14 1998-07-24 THIOUREIDO-CYCLODEXTRINS, IN PARTICULAR FOR SOLUBILIZING ANTI-TUMOR AND PEST CONTROL AGENTS AND METHODS OF PREPARING THE SAME
JP3865436B2 (en) * 1996-07-11 2007-01-10 塩水港精糖株式会社 Process for producing branched cyclodextrins
FR2779148B1 (en) 1998-05-26 2000-08-11 Centre Nat Rech Scient PROCESS FOR THE REGIOSELECTIVE PREPARATION OF C-6 MONOSULFONYL DERIVATIVES OF CYCLODEXTRINS
FR2852959B1 (en) * 2003-03-28 2008-02-15 Centre Nat Rech Scient NOVEL CYCLODEXTRIN DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND THEIR USE IN PARTICULAR FOR SOLUBILIZING PHARMACOLOGICALLY ACTIVE SUBSTANCES
FR2862649B1 (en) * 2003-11-26 2006-01-27 Centre Nat Rech Scient NOVEL CYCLODEXTRIN DIMERS AND DERIVATIVES THEREOF, PROCESSES FOR THEIR PREPARATION AND THEIR USE, IN PARTICULAR FOR THE SOLUBILIZATION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES
FR3000080B1 (en) 2012-12-20 2015-01-30 Oreal WATER INSOLUBLE CYCLODEXTRIN POLYCONDENSATE; USES AS CAPTURE AGENT
FR2999916B1 (en) 2012-12-20 2015-01-30 Oreal COMPOSITION FOR RELEASING A BENEFICIAL AGENT COMPRISING A WATER-INSOLUBLE CYCLODEXTRIN POLYCONDENSATE AND AT LEAST ONE BENEFICATED AGENT

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597872B1 (en) * 1986-04-25 1988-11-18 Beghin Say Sa PROCESS FOR THE PREPARATION OF BRANCHED OLIGO- AND POLYOSIDES, PARTICULARLY FROM STARCH
JP2775046B2 (en) * 1989-12-21 1998-07-09 農林水産省食品総合研究所長 Method for producing modified cyclodextrin containing heterosaccharide
DE4204315A1 (en) * 1992-02-13 1993-08-19 Consortium Elektrochem Ind CYCLODEXTRINGLYCOSIDES AND METHOD FOR THE PRODUCTION THEREOF
JPH06157330A (en) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd Cyclodextrin clathrate of taxol, it production and use thereof

Also Published As

Publication number Publication date
FR2716200A1 (en) 1995-08-18
WO1995021870A1 (en) 1995-08-17

Similar Documents

Publication Publication Date Title
DZ2247A1 (en) Process for the preparation of sildenafil.
DZ3079A1 (en) Process for the preparation of 4-carboxy-amino-2-substituted-1,2,3,4 tetrahydroquinole.
DZ2114A1 (en) Process for the preparation of (-) - cis-6 (s) -phenyl-5} 4- (2-pyrrolidine-1-ylethoxy) -phenylÜ-5,6,7,8-tetrahydronaphthalene-2- d-tartrate ol.
TR199600792A2 (en) Process for the preparation of dihaloazolopyrimidines.
MXPA98006731A (en) Process for producing n-acetyl-d-glucosamine.
NO981800D0 (en) Process for the preparation of 1,1,1,3,3-pentafluoropentane
DZ2135A1 (en) Process for the preparation of pure melamine.
DZ1946A1 (en) Process for the preparation of supports.
CU22890A3 (en) NEW PREPARATION PROCESS FOR PHENYLIMIDAZOLIDINE DERIVATIVES.
EP0669363A3 (en) Process for the preparation of polyorganosilane.
EP1023250A4 (en) PROCESS FOR THE PREPARATION OF 2,6-DIALKYLNAPHTALENE
FR2721598B1 (en) Process for the preparation of ammonoxidation catalysts.
FR2716200B1 (en) Process for the preparation of branched cyclomaltooligosaccharides, in particular branched cyclodextrins.
KR970702922A (en) Process for preparing doxorubicin
FR2708266B1 (en) Process for the preparation of alkanesulfonamides.
DZ2418A1 (en) Process for preparing eprosartan
FR2704773B1 (en) Process for the preparation of catalysts which can be used in dehydrogenation.
FR2695645B1 (en) Process for the preparation of polyaminoborazines.
FR2728268B1 (en) PROCESS FOR THE PREPARATION OF GAMMA-CYCLODEXTRIN
NO985535L (en) Process for the preparation of 1,3-alkanediols
DZ2770A1 (en) Process for the preparation of 1h-indol-3 glyoxamides substituted in position 4.
FR2711648B1 (en) Process for the purification of 1,1,1,2-tetrafluoroethane.
FR2714727B1 (en) Land navigation process.
GB2304339B (en) Process for producing 2-substituted optically active 2,3-dihy dro-4h-pyran-4-one
EP0643139A3 (en) Indigo preparation process.

Legal Events

Date Code Title Description
ST Notification of lapse